StockNews.com Initiates Coverage on Oncternal Therapeutics (NASDAQ:ONCT)

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the stock. Several other research firms have also recently weighed in on ONCT. Northland Capmk cut shares of Oncternal Therapeutics from a strong-buy rating to a hold rating in a […]

Leave a Reply

Your email address will not be published.

Previous post JPMorgan Chase & Co. Upgrades Fortive (NYSE:FTV) to Overweight
Next post Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com